Major depressive disorder affects approximately 15 million American adults in the U.S. in a given year, and a first pharmacological line of defense is often a prescription for an SSRI such as Prozac, Celexa, or Zoloft

Original post:
An atypical antidepressant for atypical depression: Consider Wellbutrin if SSRIs have failed

Well, actually, I’m sure there’s more than one thing.

View original post here:
Here’s one thing that Big Pharma and Russian mobsters have in common

I received the following message the other day from one of our blog’s readers, Susanna Brooks: I cannot believe that I cannot buy drugs in Canada (with a prescription). It’s been the only way that I can get some of the medications that I need that are ungodly expensive in the United States. I will work to vote against any Senator/Congressman that votes against the Canadian medications being sold/deliver in the U.S.A.!! Sharing Susanna’s Sentiments I know for a fact that tens of millions of people share Susanna’s sentiments

Go here to read the rest:
Reflecting on the sad, sordid history of Canadian drug reimportation legislation

We’re written before about U.S. Senator David Vitter’s quixotic fight to legalize the purchase of Canadian drugs by Americans — long after the battle over reimportation has been lost in a thick haze of Big Pharma backroom bargaining with the White House. Last week, Vitter — a Republican — took some heat from liberals by explaining at a town hall meeting that he hoped to de-stabilize pricing in Canada and other countries with “socialized medicine” by legalizing reimportation.

More here:
Honestly, David Vitter, we like your thinking